Background/Aim: This study aimed to compare the cortical excitability of patients with generalized tonic-clonic seizures (GTCSs) and that of patients with psychogenic non-epileptic seizures (PNESs). Methods: Patients were classified into groups according to their electroencephalogram (EEG) findings and seizure types: group 1 = GTCS with an abnormal EEG, group 2 = GTCS with a normal EEG and group 3 = PNES with a normal EEG. The control group included healthy volunteers with normal EEGs. Cortical silent period (CSP) and motor threshold (MT) were measured for all groups and the results were compared. Results: CSPs were significantly prolonged in groups 1 and 2 when compared with group 3 and the control group. No differences were found between the MT measurements of all groups. Conclusion: The prolongation of CSP may demonstrate the differences between the pathophysiological mechanisms of GTCS and those of PNES.

1.
Avanzini G, Franceschetti S: Cellular biology of epileptogenesis. Lancet Neurol 2003;2:33–42.
2.
Cragar DE, Berry DT, Fakhoury TA, Cibula JE: A review of diagnostic techniques in the differential diagnosis of epileptic and nonepileptic seizures. Neuropsychiol Rev 2002;12:31–64.
3.
Oguni H: Diagnosis and treatment of epilepsy. Epilepsia 2004;45(suppl 8):13–16.
4.
Reuber M, Fernandez G, Bauer J, Helmstaedter C: Diagnostic delay in psychogenic nonepileptic seizures. Neurology 2002;58:493–495.
5.
Reuber M, Fernandez G, Bauer J, Singh DD, Elger CE: Interictal EEG abnormalities in patients with psychogenic nonepileptic seizures. Epilepsia 2002;43:1013–1020.
6.
Benbadis SR: The EEG in nonepileptic seizures. J Clin Neurophysiol 2006;23:340–352.
7.
Kotsopoulos I, de Krom M, Kessels F, Lodder J, Trosst J, Twellaar M, van Merode T, Knottnerus A: Incidence of epilepsy and predictive factors of epileptic and non-epileptic seizures. Seizure 2005;14:175–182.
8.
Hadjikoutis S, O’Callaghan P, Smith PE: The investigation of syncope. Seizure 2004;13:537–548.
9.
Jedrzejczak J, Owczarek K, Majkowski J: Psychogenic pseudoepileptic seizures: clinical and electroencephalogram (EEG) video-tape recordings. Eur J Neurol 1999;6:473–479.
10.
Müller T, Merschhemke M, Dehnicke C, Sanders M, Meencke HJ: Improving diagnostic procedure and treatment in patients with non-epileptic seizures (NES). Seizure 2002;11:85–89.
11.
Reuber M, Qurishi A, Bauer J, Helmstaedter C, Fernandez G, Widman G, Elger CE: Are there physical risk factors for psychogenic non-epileptic seizures in patients with epilepsy? Seizure 2003;12:561–567.
12.
Shulka G, Bhatia M, Vivekanandhan S, Gupta N, Tripathi M, Srivastava A, Pandey RM, Jain S: Serum prolactin levels for differentiation of nonepileptic versus true seizures: limited utility. Epilepsy Behav 2004;5:517–521.
13.
Smith SJ: EEG in the diagnosis, classification, and management of patients with epilepsy. J. Neurol Neurosurg Psychiatry 2005;76(suppl 2):ii2–ii7.
14.
Tatum WO 4th: Long-term EEG monitoring: a clinical approach to electrophysiology. J Clin Neurophysiol 2001;18:442–455.
15.
Chen R, Lozano AM, Ashby P: Mechanism of the silent period following transcranial magnetic stimulation. Evidence from epidural recordings. Exp Brain Res 1999;128:539–542.
16.
Cincotta M, Borgheresi A, Lor, S, Fabbri M, Zaccara G: Interictal inhibitory mechanisms in patients with cryptogenic motor cortex epilepsy: a study of the silent period following transcranial magnetic stimulation. Electroencephalogr Clin Neurophysiol 1998;107:1–7.
17.
Hamer HM, Reis J, Mueller HH, Knake S, Overhof M, Oertel WH, Rosenow F: Motor cortex excitability in focal epilepsies not including the primary motor area – a TMS study. Brain 2005;128:811–818.
18.
Macdonell RA, King MA, Newton MR, Curatolo JM, Reutens DC, Berkovic SF: Prolonged cortical silent period after transcranial magnetic stimulation in generalized epilepsy. Neurology 2001;57:706–708.
19.
Macdonell RA, Curatolo JM, Berkovic SF: Transcranial magnetic stimulation and epilepsy. J Clini Neurophysiol 2002;19:294–306.
20.
Tassinari CA, Cincotta M, Zaccara G, Michelucci R: Transcranial magnetic stimulation and epilepsy. Clin Neurophysiol 2003;114:777–798.
21.
Tataraoglu C, Ozkiziltan S, Baklan B: Motor cortical thresholds and cortical silent periods in epilepsy. Seizure 2004;13:481–485.
22.
Alisauskiene M, Truffert A, Vaiciene N, Magistris MR: Transcranial magnetic stimulation in clinical practice. Medicina (Kaunas) 2005;41:813–824.
23.
Ziemann U, Steinhoff BJ, Tergau F, Paulus W: Transcranial magnetic stimulation: its current role in epilepsy research. Epilepsy Res 1998;30:11–30.
24.
Ziemann U: TMS and drugs. Clin Neurophysiol 2004;115:1717–1729.
25.
Knecht S, Sommer J, Deppe M, Steinsträter O: Scalp position and efficacy of transcranial magnetic stimulation. Clin Neurophysiol 2005;116:1988–1993.
26.
Avoli M, Louvel J, Pumain R, Köhling R: Cellular and molecular mechanisms of epilepsy in the human brain. Prog Neurobiol 2005;77:166–200.
27.
Reuber M, Pukrop R, Bauer J, Helmstaedter C, Tessendorf N, Elger CE: Outcome in psychogenic nonepileptic seizures: 1 to 10-year follow-up in 164 patients. Ann Neurol 2003;53:305–311.
28.
Bowery NG, Smart TG: GABA and glycine as neurotransmitters: a brief history. Br J Pharmacol 2006;147(suppl 1):S109–S119.
29.
Di Lazzaro V, Oliviero A, Meglio M, Cioni B, Tamburrini G, Tonali P, Rothwell JC: Direct demonstration of the effect of lorazepam on the excitability of the human motor cortex. Clin Neurophysiol 2000;111:794–799.
30.
McDonnel MN, Orekhov Y, Ziemann U: The role of GABA(B) receptors in intracortical inhibition in the human motor cortex. Exp Brain Res 2006;173:86–93.
31.
Treiman DM: GABAergic mechanisms in epilepsy. Epilepsia 2001;42(suppl 3):8–12.
32.
Terao Y, Ugawa Y: Basic mechanisms of TMS. J Clin Neurophysiol 2002;19:322–343.
33.
Kazis DA, Kimiskidis VK, Papagiannopoulos S, Sotirakoglou K, Divanoglou D, Vlaikidis N, Mills KR, Kazis A: The effect of valproate on silent period and corticomotor excitability. Epileptic Disord 2006;8:136–142.
34.
Lefaucheur JP: Excitability of the motor cortical representation of the external anal sphincter. Exp Brain Res 2005;160:268–272.
35.
Rosa MA, Odebrecht M, Rigonatti SP, Marcolin MA: Transcranial magnetic stimulation: review of accidental seizures (article in Portuguese). Rev Bras Psiquiatr 2004;26:131–134.
36.
Schrader LM, Stern JM, Koski L, Nuwer MR, Engel J Jr: Seizure incidence during single- and paired-pulse transcranial magnetic stimulation (TMS) in individuals with epilepsy. Clin Neurophysiol 2004;115:2728–2737.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.